Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy
Publication
, Journal Article
Jeter, A; Kang, Y
Published in: Experimental Hematology & Oncology
December 2012
Duke Scholars
Published In
Experimental Hematology & Oncology
DOI
EISSN
2162-3619
Publication Date
December 2012
Volume
1
Issue
1
Publisher
Springer Science and Business Media LLC
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Jeter, A., & Kang, Y. (2012). Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy. Experimental Hematology & Oncology, 1(1). https://doi.org/10.1186/2162-3619-1-20
Jeter, Ashley, and Yubin Kang. “Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy.” Experimental Hematology & Oncology 1, no. 1 (December 2012). https://doi.org/10.1186/2162-3619-1-20.
Jeter A, Kang Y. Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy. Experimental Hematology & Oncology. 2012 Dec;1(1).
Jeter, Ashley, and Yubin Kang. “Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy.” Experimental Hematology & Oncology, vol. 1, no. 1, Springer Science and Business Media LLC, Dec. 2012. Crossref, doi:10.1186/2162-3619-1-20.
Jeter A, Kang Y. Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy. Experimental Hematology & Oncology. Springer Science and Business Media LLC; 2012 Dec;1(1).
Published In
Experimental Hematology & Oncology
DOI
EISSN
2162-3619
Publication Date
December 2012
Volume
1
Issue
1
Publisher
Springer Science and Business Media LLC
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3201 Cardiovascular medicine and haematology